Mitochondrial β-oxidation of adipose-derived fatty acids by osteoblasts fuels parathyroid hormone-induced bone formation.
Adipose tissue
Bone Biology
Fatty acid oxidation
Osteoporosis
Journal
JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073
Informations de publication
Date de publication:
22 03 2023
22 03 2023
Historique:
received:
20
09
2022
accepted:
01
02
2023
pubmed:
3
2
2023
medline:
24
3
2023
entrez:
2
2
2023
Statut:
epublish
Résumé
The energetic costs of bone formation require osteoblasts to coordinate their activities with tissues, like adipose, that can supply energy-dense macronutrients. In the case of intermittent parathyroid hormone (PTH) treatment, a strategy used to reduce fracture risk, bone formation is preceded by a change in systemic lipid homeostasis. To investigate the requirement for fatty acid oxidation by osteoblasts during PTH-induced bone formation, we subjected mice with osteoblast-specific deficiency of mitochondrial long-chain β-oxidation as well as mice with adipocyte-specific deficiency for the PTH receptor or adipose triglyceride lipase to an anabolic treatment regimen. PTH increased the release of fatty acids from adipocytes and β-oxidation by osteoblasts, while the genetic mouse models were resistant to the hormone's anabolic effect. Collectively, these data suggest that PTH's anabolic actions require coordinated signaling between bone and adipose, wherein a lipolytic response liberates fatty acids that are oxidized by osteoblasts to fuel bone formation.
Identifiants
pubmed: 36729662
pii: 165604
doi: 10.1172/jci.insight.165604
pmc: PMC10070112
doi:
pii:
Substances chimiques
Parathyroid Hormone
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIAMS NIH HHS
ID : R01 AR077533
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK120530
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK099134
Pays : United States
Références
Cell Metab. 2013 Jun 4;17(6):901-915
pubmed: 23684624
Metabolism. 1976 Mar;25(3):251-60
pubmed: 175239
J Lancet. 1958 May;78(5):190-6
pubmed: 13525858
Nat Cell Biol. 2010 Mar;12(3):224-34
pubmed: 20139972
J Bone Miner Res. 2015 Nov;30(11):1959-68
pubmed: 25990470
J Bone Miner Res. 2010 Jul;25(7):1468-86
pubmed: 20533309
Cell Metab. 2017 Mar 7;25(3):661-672
pubmed: 28162969
Nat Methods. 2015 Apr;12(4):357-60
pubmed: 25751142
J Bone Miner Res. 2021 Mar;36(3):604-616
pubmed: 33253422
N Engl J Med. 1994 Dec 15;331(24):1618-23
pubmed: 7969342
N Engl J Med. 2001 May 10;344(19):1434-41
pubmed: 11346808
J Biol Chem. 2002 Nov 15;277(46):44005-12
pubmed: 12215457
PLoS Genet. 2019 Jun 24;15(6):e1008244
pubmed: 31233501
Cell Rep. 2016 Feb 16;14(6):1308-1316
pubmed: 26854223
Elife. 2022 Jun 22;11:
pubmed: 35731039
Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2732-6
pubmed: 1313566
J Bone Miner Res. 2013 Jan;28(1):2-17
pubmed: 23197339
Endocrinology. 1999 Aug;140(8):3552-61
pubmed: 10433211
Osteoporos Int. 2014 Feb;25(2):467-74
pubmed: 23779082
Osteoporos Int. 1994 Nov;4(6):362-7
pubmed: 7696834
Development. 2002 Jun;129(12):2977-86
pubmed: 12050144
Nature. 2005 Mar 24;434(7032):514-20
pubmed: 15724149
Endocrinology. 1995 Aug;136(8):3632-8
pubmed: 7628403
J Biol Chem. 1994 Oct 21;269(42):26443-8
pubmed: 7929365
Cell. 2015 Jun 18;161(7):1576-1591
pubmed: 26091038
J Clin Invest. 1993 Jun;91(6):2479-87
pubmed: 8514860
Nat Biotechnol. 2015 Mar;33(3):290-5
pubmed: 25690850
JCI Insight. 2017 Aug 17;2(16):
pubmed: 28814665
Cold Spring Harb Perspect Med. 2018 Aug 1;8(8):
pubmed: 29358318
FASEB J. 2019 Feb;33(2):2885-2898
pubmed: 30354669
Cell Rep. 2015 Jan 13;10(2):266-79
pubmed: 25578732
Am J Physiol Endocrinol Metab. 2015 May 15;308(10):E879-90
pubmed: 25783895
J Clin Endocrinol Metab. 2008 Sep;93(9):3462-70
pubmed: 18544625
Bone. 2012 Feb;50(2):576-9
pubmed: 21549867
Endocrinology. 2015 Oct;156(10):3610-24
pubmed: 26196542
J Bone Miner Res. 2002 Sep;17(9):1570-8
pubmed: 12211426
J Bone Miner Res. 1988 Aug;3(4):431-8
pubmed: 3223357
J Exp Med. 2011 Apr 11;208(4):841-51
pubmed: 21444660
J Biol Chem. 2007 Nov 9;282(45):33086-97
pubmed: 17690103
Cell Stem Cell. 2010 Nov 5;7(5):571-80
pubmed: 21040899
J Bone Miner Res. 2013 Oct;28(10):2094-108
pubmed: 23609180
Biochem J. 1987 Nov 15;248(1):129-37
pubmed: 3325035
Diabetes. 2013 Oct;62(10):3350-61
pubmed: 23835334
J Clin Invest. 1999 Aug;104(4):439-46
pubmed: 10449436
Endocrinol Metab Clin North Am. 2018 Dec;47(4):743-758
pubmed: 30390810
J Clin Invest. 2017 Sep 1;127(9):3327-3338
pubmed: 28758904
Endocrinology. 2005 May;146(5):2171-5
pubmed: 15705779
N Engl J Med. 1999 Oct 21;341(17):1249-55
pubmed: 10528034
Biogerontology. 2001;2(3):165-71
pubmed: 11708718
Endocrinology. 1997 Nov;138(11):4607-12
pubmed: 9348185
Cell Metab. 2011 Mar 2;13(3):249-59
pubmed: 21356515
Am J Physiol. 1978 Jan;234(1):C51-5
pubmed: 23680
Am J Physiol. 1978 Jan;234(1):C41-50
pubmed: 623240
Front Endocrinol (Lausanne). 2022 Mar 11;13:853765
pubmed: 35360075
J Biol Chem. 2016 Jan 22;291(4):1631-1642
pubmed: 26598522